Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsSecuritiesSecurities - Mortgage Backed SecuritiesSecurities - TradableShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Old Second Bancorp (OSBC) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Old Second Bancorp (OSBC) over the last 10 years, with Q3 2025 value amounting to $116.5 million.

  • Old Second Bancorp's Cash & Equivalents rose 65.48% to $116.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $116.5 million, marking a year-over-year increase of 65.48%. This contributed to the annual value of $99.3 million for FY2024, which is 81.48% down from last year.
  • Old Second Bancorp's Cash & Equivalents amounted to $116.5 million in Q3 2025, which was up 65.48% from $141.8 million recorded in Q2 2025.
  • In the past 5 years, Old Second Bancorp's Cash & Equivalents ranged from a high of $752.1 million in Q4 2021 and a low of $98.1 million during Q1 2024
  • In the last 5 years, Old Second Bancorp's Cash & Equivalents had a median value of $116.5 million in 2025 and averaged $254.0 million.
  • As far as peak fluctuations go, Old Second Bancorp's Cash & Equivalents surged by 50289.45% in 2021, and later crashed by 8468.3% in 2022.
  • Old Second Bancorp's Cash & Equivalents (Quarter) stood at $752.1 million in 2021, then crashed by 84.68% to $115.2 million in 2022, then fell by 13.07% to $100.1 million in 2023, then decreased by 0.81% to $99.3 million in 2024, then rose by 17.31% to $116.5 million in 2025.
  • Its Cash & Equivalents stands at $116.5 million for Q3 2025, versus $141.8 million for Q2 2025 and $256.1 million for Q1 2025.